Evidence map›Paper›PMID 25126734›Full record

ArticleAutophagy2014

Endoplasmic reticulum stress induced by tunicamycin and thapsigargin protects against transient ischemic brain injury: Involvement of PARK2-dependent mitophagy.

Xiangnan Zhang, Yang Yuan, Lei Jiang, Jingying Zhang, Jieqiong Gao, Zhe Shen, Yanrong Zheng, Tian Deng, Haijing Yan, Wenlu Li and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 153 papers.

0numbers the graph read from it
0cells of the map it votes in
153citing papers in PubMed
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

153 citing papers in PubMed, 271 citations in OpenAlex.

  1. Mitophagy coordinates organelle crosstalk in health and diseases.Signal transduction and targeted therapy · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Parkin protects against traumatic brain injury through regulating mitochondrial quality control.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. The Tumor Suppressor TPD52-Governed Endoplasmic Reticulum Stress is Modulated by APCAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review

93 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 3 countries.

Xiangnan ZhangDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China; Collaborative Innovation Center for Infectious Diseases; Zhejiang University; Hangzhou, China.
Yang YuanDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Lei JiangDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Jingying ZhangDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Jieqiong GaoZhejiang Provincial Key Laboratory of Medical Genetics; School of Life Sciences; Wenzhou Medical College; Wenzhou, China.
Zhe ShenDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Yanrong ZhengDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Tian DengDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Haijing YanDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Wenlu LiDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China; Department of Pharmacy; the Second Affiliated Hospital; School of Medicine; Zhejiang University; Hangzhou, China.
Wei-Wei HouDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China.
Jianxin LuZhejiang Provincial Key Laboratory of Medical Genetics; School of Life Sciences; Wenzhou Medical College; Wenzhou, China.
Yao ShenZhejiang Provincial Key Laboratory of Medical Genetics; School of Life Sciences; Wenzhou Medical College; Wenzhou, China.
Haibing DaiDepartment of Pharmacy; the Second Affiliated Hospital; School of Medicine; Zhejiang University; Hangzhou, China.
Wei-Wei HuDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China; Collaborative Innovation Center for Infectious Diseases; Zhejiang University; Hangzhou, China.
Zhuohua ZhangState Key Laboratory of Medical Genetics; Central South University; Changsha, China.
Zhong ChenDepartment of Pharmacology; Key Laboratory of Medical Neurobiology of the Ministry of Health of China; Zhejiang Province Key Laboratory of Neurobiology; College of Pharmaceutical Sciences; Zhejiang University; Hangzhou, China; Collaborative Innovation Center for Infectious Diseases; Zhejiang University; Hangzhou, China.
Zhejiang University · CNInstitute of Neurobiology · BGPharmaceutical Biotechnology (Czechia) · CZWenzhou Medical University · CNIndiana University School of MedicineLaboratoire de Génétique Médicale

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transient cerebral ischemia leads to endoplasmic reticulum (ER) stress. However, the contributions of ER stress to cerebral ischemia are not clear. To address this issue, the ER stress activators tunicamycin (TM) and thapsigargin (TG) were administered to transient middle cerebral artery occluded (tMCAO) mice and oxygen-glucose deprivation-reperfusion (OGD-Rep.)-treated neurons. Both TM and TG showed significant protection against ischemia-induced brain injury, as revealed by reduced brain infarct volume and increased glucose uptake rate in ischemic tissue. In OGD-Rep.-treated neurons, 4-PBA, the ER stress releasing mechanism, counteracted the neuronal protection of TM and TG, which also supports a protective role of ER stress in transient brain ischemia. Knocking down the ER stress sensor Eif2s1, which is further activated by TM and TG, reduced the OGD-Rep.-induced neuronal cell death. In addition, both TM and TG prevented PARK2 loss, promoted its recruitment to mitochondria, and activated mitophagy during reperfusion after ischemia. The neuroprotection of TM and TG was reversed by autophagy inhibition (3-methyladenine and Atg7 knockdown) as well as Park2 silencing. The neuroprotection was also diminished in Park2(+/-) mice. Moreover, Eif2s1 and downstream Atf4 silencing reduced PARK2 expression, impaired mitophagy induction, and counteracted the neuroprotection. Taken together, the present investigation demonstrates that the ER stress induced by TM and TG protects against the transient ischemic brain injury. The PARK2-mediated mitophagy may be underlying the protection of ER stress. These findings may provide a new strategy to rescue ischemic brains by inducing mitophagy through ER stress activation.

Indexed as

Endoplasmic Reticulum StressMitophagyAnimalsApoptosisBrain IschemiaGlucoseMiceNeuroprotective AgentsOxygenReperfusion InjurySignal TransductionThapsigarginTunicamycinUbiquitin-Protein LigasesGlucoseNeuroprotective AgentsOxygenparkin proteinThapsigarginTunicamycinUbiquitin-Protein Ligasescerebral ischemiaendoplasmic reticulum stressmitophagyneuroprotectionPARK2

Identifiers

PMID25126734
PMCPMC4198364
OpenAlexW1705639264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.